• Skip to main content
logo-4800
  • Home
  • Team
  • Portfolio
  • News
  • Contact Us
×
  • Home
  • Team
  • Portfolio
  • News
  • Contact Us

PORTFOLIO COMPANIES

Gold Nest Life Science I Portfolio Companies

A Gold Nest Life Science I Portfolio Company
A Gold Nest Life Science I Portfolio Company

Dynamic Biosensors

Enabling Technology

  • High throughput label-free biosensor for drug development and diagnostics
  • switchSENSE® - superior performance for multi-specific, nucleic acid, low affinity measurement and beyond
  • cellTrap® - enabling kinetic measurement on live cells
A Gold Nest Life Science I Portfolio Company
A Gold Nest Life Science I Portfolio Company

BiosanaPharna

Therapeutics & Enabling Technology

  • Fully continuous, small footprint and high yield manufacturing process for biologic drugs
  • Reducing mAb manufacturing cost by up to 90%
  • Proprietary mAb pipeline for validation of manufacturing process
A Gold Nest Life Science I Portfolio Company
A Gold Nest Life Science I Portfolio Company

Mimetas

Enabling Technology

  • OrganoPlate® patented Organ-on-a-Chip
  • Microfluidic 3D cell/tissue culture technology
  • Phenotypic disease models that better mimic human disease conditions accelerate drug development

EMBL Ventures Portfolio Companies

An EMBL Ventures Portfolio Company
An EMBL Ventures Portfolio Company

Bufferfly Network

Enabling Technology

IPO via SPAC on NYSE

  • Portable smartphone-connected ultrasound system
  • Democratize healthcare by making medical imaging accessible to everyone around the world
An EMBL Ventures Portfolio Company
An EMBL Ventures Portfolio Company

Jiff

Others

Acquired by Castlight Health

  • Health benefits platform designed for enterprises
  • Help companies lower healthcare costs and cultivate happier, healthier employees
An EMBL Ventures Portfolio Company
An EMBL Ventures Portfolio Company

Decipher Biosciences

Enabling Technology

Acquired by Veracyte

  • RNA biomarker-based stratification testing for prostate cancer
  • Predicts likelihood of metastases and cancer-specific mortality
  • Help physician determine optimal treatment plan and avoid debilitating overtreatment for patients
An EMBL Ventures Portfolio Company
An EMBL Ventures Portfolio Company

SONETIK

Others

  • Hearing aid with novel distribution model
  • High quality hearing tests and hearing aids ready to be sold in pharmacies without acoustic specialist consultation
An EMBL Ventures Portfolio Company
An EMBL Ventures Portfolio Company

Topas therapeutics

Therapeutics

  • Liver-targeting peptides that induce antigen-specific immune tolerance, addressing unmet needs in autoimmune, allergies, and anti-drug antibodies.
  • Harness the natural mechanisms of the liver to promote immune tolerance to blood borne antigens
  • Proprietary Topas Particle Conjugates (TPCs): polymer-cpoated iron oxide nanoparticles conjugated with disease-relevant peptides.
An EMBL Ventures Portfolio Company
An EMBL Ventures Portfolio Company

Arsanis

Therapeutics

IPO on NASDAQ

  • Monoclonal antibody (mAb) immunotherapies for serious infectious diseases
  • mAb cocktails that bind bacterial toxins and prevent sepsis in ICU patients
An EMBL Ventures Portfolio Company
An EMBL Ventures Portfolio Company

viratherapeutics

Therapeutics

Acquired by Boehringer Ingelheim

  • Oncolytic viral therapy for cancer treatment
  • Produced via proprietary VSV-GP platform: envelope protein reprogramed to be less neurotoxic, less immunogenic, and more efficacious
  • Able to administer intravenously instead of intratumorally
An EMBL Ventures Portfolio Company
An EMBL Ventures Portfolio Company

Luxendo

Enabling Technology

Acquired by Bruker

  • Light-sheet fluorescence microscopy instrument for biological samples
  • Leverage single-plane illumination microscopy (SPIM) technology to avoid phototoxicity and allow observing fragile living samples for extended periods of time
An EMBL Ventures Portfolio Company
An EMBL Ventures Portfolio Company

Lipids therapeutics

Therapeutics

  • Lipid-based therapies for treating inflammatory diseases of the digestive system

© Copyright 2023 Gold Nest Capital. All Rights Reserved.

  • WordPress Web Design